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tions in our series.
CONCLUSION
Endovascular management of emergency cases of ABF
and AEF is associated with poor results. Patients with AEF
treated with TEVAR appear to have an inferior outcome
compared to patients with ABF. TEVAR does prevent
immediate exsanguination in patients admitted with AEF
and ABF but after initial deployment of the endograft and
control of the hemodynamic status, most patients, in par-
ticular those with AEF, are at risk for infectious complica-
tions. Early esophageal repair appears to improve the sur-
vival in case of AEF. Therefore, TEVAR may serve as a
bridge to surgery in emergency cases of AEF with subse-
quent definitive open operative repair of the esophageal
defect as soon as possible. In patients with ABF, additional
open surgery may not be necessary after the endovascular
procedure.
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Mercifully, fistulous communications between the aorta and exsanguination, or be prolonged due to sepsis. The former threat isremedied by prompt treatment of the defect in the aorta, the latter
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Volume 50, Number 5 Carpenter 1005by repair of the defect in the aerodigestive tract. Both are formi-
dable undertakings, usually in patients with prior chest surgery and
multiple comorbidities now further compromised by acute blood
loss or sepsis.
Immediate death due to exsanguination may be prevented by
thoracic endovascular aneurysm repair (TEVAR) to plug the hole
in the aorta. However, this does nothing to address the issue of the
defect in the aerodigestive tract, leaving the patients at risk for a
septic demise. In the reports by Riesenman and Jonker, although
TEVAR was effective in reducing the immediate mortality due to
exsanguinations, the overall mortality rate in these two series was
still quite high (20% to 45%). The best results in these two series
were in those patients who underwent prompt repair of the aero-
digestive tract defect after stabilization of bleeding by TEVAR.
The most efficacious use of TEVAR appears to be that of a
hemostatic device to convert the situation from emergent to
urgent. Prompt surgical repair of the defect in the aerodigestive
tract is essential to prevent later complications from ongoing
contamination due to the untreated communication with esopha-
gus or bronchus. Once hemostasis is obtained and the patient
stabilized, repair of the fistula should not be delayed. Recurrence of
both bleeding and sepsis is high, likely due to chronic graft
infection, if the fistula is not surgically corrected. Complicationscations from bronchial communications, suggesting that the
spilled esophageal contents are more virulent than is communica-
tion with the open air. Both, however, are ultimately lethal if
untreated.
Controversy arises regarding the nature of the aortic repair. Is
TEVAR sufficient and definitive, or is it a bridge to another
solution? These series have demonstrated that TEVAR will fail due
to infection of the graft in a significant number of cases, reinforcing
the concept of TEVAR as a stopgap measure rather than a defini-
tive repair. This is not surprising, given the time-honored surgical
maxim of removal of all prosthetic from a contaminated field. The
failures of TEVAR as a definitive strategy were more frequent and
faster for the esophageal than for the bronchial fistula group. The
safest aortic strategy appears to be that of extra-anatomic aortic
reconstruction or in situ allograft replacement of the aorta with
explant of the TEVAR at the time of fistula repair, although
experience is limited.
Clearly, any strategy in this patient population needs to be
highly individualized given the risks of major thoracic surgery
(often reoperative). These present reports alert us to the utility of
TEVAR in the immediate management of these challenging pa-
tients and caution us about its inadequacy as a definitive solutionfrom esophageal defects appear to arise more quickly than compli- for this condition.
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